BACKGROUND: The inefficiency of HIV breast-milk transmission may be caused by the presence of immunologically active factors, including human milk oligosaccharides (HMOs). OBJECTIVE: We investigated whether HMO concentrations are associated with a reduced risk of postnatal HIV transmission. DESIGN: A nested case-control study was conducted within a larger cohort study of HIV-infected women and their infants followed from birth to 24 mo in Lusaka, Zambia. Breast-milk samples collected at 1 mo from 81 HIV-infected women who transmitted via breastfeeding, a random sample of 86 HIV-infected women who did not transmit despite breastfeeding, and 36 uninfected breastfeeding women were selected. Total and specific HMO concentrations were measured by HPLC and compared between groups with adjustment for confounders by using logistic regression. RESULTS: HIV-infected women with total HMOs above the median (1.87 g/L) were less likely to transmit via breastfeeding (OR: 0.45; 95% CI: 0.21, 0.97; P = 0.04) after adjustment for CD4 count and breast-milk HIV RNA concentrations; a trend toward higher concentrations of lacto-N-neotetraose being associated with reduced transmission (OR: 0.49; 95% CI: 0.23, 1.04; P = 0.06) was also observed. The proportion of 3'-sialyllactose (3'-SL) per total HMOs was higher among transmitting than among nontransmitting women (P = 0.003) and correlated with higher plasma and breast-milk HIV RNA and lower CD4 counts. Neither Secretor nor Lewis status distinguished between transmitting and nontransmitting women. CONCLUSIONS: Higher concentrations of non-3'-SL HMOs were associated with protection against postnatal HIV transmission independent of other known risk factors. Further study of these novel, potentially anti-HIV components of breast milk is warranted.
RCT Entities:
BACKGROUND: The inefficiency of HIV breast-milk transmission may be caused by the presence of immunologically active factors, including humanmilk oligosaccharides (HMOs). OBJECTIVE: We investigated whether HMO concentrations are associated with a reduced risk of postnatal HIV transmission. DESIGN: A nested case-control study was conducted within a larger cohort study of HIV-infectedwomen and their infants followed from birth to 24 mo in Lusaka, Zambia. Breast-milk samples collected at 1 mo from 81 HIV-infectedwomen who transmitted via breastfeeding, a random sample of 86 HIV-infectedwomen who did not transmit despite breastfeeding, and 36 uninfected breastfeeding women were selected. Total and specific HMO concentrations were measured by HPLC and compared between groups with adjustment for confounders by using logistic regression. RESULTS:HIV-infectedwomen with total HMOs above the median (1.87 g/L) were less likely to transmit via breastfeeding (OR: 0.45; 95% CI: 0.21, 0.97; P = 0.04) after adjustment for CD4 count and breast-milk HIV RNA concentrations; a trend toward higher concentrations of lacto-N-neotetraose being associated with reduced transmission (OR: 0.49; 95% CI: 0.23, 1.04; P = 0.06) was also observed. The proportion of 3'-sialyllactose (3'-SL) per total HMOs was higher among transmitting than among nontransmitting women (P = 0.003) and correlated with higher plasma and breast-milk HIV RNA and lower CD4 counts. Neither Secretor nor Lewis status distinguished between transmitting and nontransmitting women. CONCLUSIONS: Higher concentrations of non-3'-SL HMOs were associated with protection against postnatal HIV transmission independent of other known risk factors. Further study of these novel, potentially anti-HIV components of breast milk is warranted.
Authors: Lars Bode; Clemens Kunz; Marion Muhly-Reinholz; Konstantin Mayer; Werner Seeger; Silvia Rudloff Journal: Thromb Haemost Date: 2004-12 Impact factor: 5.249
Authors: Ardythe L Morrow; Guillermo M Ruiz-Palacios; Mekibib Altaye; Xi Jiang; M Lourdes Guerrero; Jareen K Meinzen-Derr; Tibor Farkas; Prasoon Chaturvedi; Larry K Pickering; David S Newburg Journal: J Pediatr Date: 2004-09 Impact factor: 4.406
Authors: Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; Lisa W Stamper; Genevieve G Fouda; Sallie R Permar; Katie Hinde; Louise Kuhn; Lars Bode; Grace M Aldrovandi; J Victor Garcia Journal: J Virol Date: 2015-08-19 Impact factor: 5.103
Authors: Gege Xu; Jasmine Cc Davis; Elisha Goonatilleke; Jennifer T Smilowitz; J Bruce German; Carlito B Lebrilla Journal: J Nutr Date: 2016-10-19 Impact factor: 4.798
Authors: Genevieve G Fouda; Frederick H Jaeger; Joshua D Amos; Carrie Ho; Erika L Kunz; Kara Anasti; Lisa W Stamper; Brooke E Liebl; Kimberly H Barbas; Tomoo Ohashi; Martin Arthur Moseley; Hua-Xin Liao; Harold P Erickson; S Munir Alam; Sallie R Permar Journal: Proc Natl Acad Sci U S A Date: 2013-10-21 Impact factor: 11.205